Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney
- 10 November 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 50 (1) , 39-51
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82374138)
This publication has 35 references indexed in Scilit:
- Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90α, and RXRαPhytomedicine, 2022
- Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data ReportKidney International, 2020
- Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patientsEuropean Journal of Internal Medicine, 2019
- Codonopsis tangshen Oliv. Amelioration Effect on Diabetic Kidney Disease Rats Induced by High Fat Diet Feeding Combined with StreptozotocinNatural Products and Bioprospecting, 2018
- Relationships of Changes in Pharmacokinetic Parameters of Substrate Drugs in Drug-Drug Interactions on Metabolizing Enzymes and TransportersThe Journal of Clinical Pharmacology, 2018
- Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2Journal of Ethnopharmacology, 2016
- Tissue Processing and Hematoxylin and Eosin Staining2014
- Effects of chronic kidney disease and uremia on hepatic drug metabolism and transportKidney International, 2014
- Quantitative Real-Time PCR-Based Analysis of Gene Expression2011
- Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element bindingBiochemical and Biophysical Research Communications, 2010